Discover
OSTX
OS Therapies Incorporated
1.62
1800 x 1.61
400 x 1.64
bid
ask
+
0.00
0.00%
1100 @ 07:54 PM
1.64 +0.02 (1.04%)
| Ytd | 15.71% | |
| 1y | -20.59% |
1.59
day range
1.66
1.16
52 week range
2.24
| Open | 1.62 | Prev Close | 1.62 | Low | 1.59 | High | 1.66 | Mkt Cap | 75.82M |
| Vol | 422.13K | Avg Vol | 586.70K | EPS | -1.08 | P/E | N/A | Forward P/E | 2.57 |
| Beta | -0.64 | Short Ratio | 1.22 | Inst. Own | 0.75% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-16 | 50-d Avg | 1.65 | 200-d Avg | 1.58 | 1yr Est | 12.67 |
| Income Statement | |||
| Operating Expenses | 8.58M | ||
| Research and Development Expense | 6.07M | ||
| Selling, General and Administrative Expense | 2.50M | ||
| Operating Income | -8.58M | ||
| Interest Expense | 5.58K | ||
| Net Income | -8.63M | ||
| Net Income Common Stock | -8.63M | ||
| Net Income Common Stock (USD) | -8.63M | ||
| Consolidated Income | -8.63M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -8.63M | ||
| Earning Before Interest & Taxes (USD) | -8.63M | ||
| Weighted Average Shares | 43.90M | ||
| Weighted Average Shares Diluted | 43.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 205.04K | ||
| Cash and Equivalents (USD) | 205.04K | ||
| Current Assets | 3.64M | ||
| Property, Plant & Equipment Net | 1.10K | ||
| Total Assets | 9.90M | ||
| Current Liabilities | 20.64M | ||
| Total Liabilities | 20.74M | ||
| Accumulated Retained Earnings (Deficit) | -86.22M | ||
| Shareholders Equity | -11.91M | ||
| Shareholders Equity (USD) | -11.91M | ||
| Assets Non-Current | 6.26M | ||
| Goodwill and Intangible Assets | 6.26M | ||
| Liabilities Non-Current | 100.00K | ||
| Trade and Non-Trade Payables | 20.62M | ||
| Tax Assets | 3.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 124.94K | ||
| Net Cash Flow from Financing | 4.82M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -712.52K | ||
| Issuance (Purchase) of Equity Shares | 4.82M | ||
| Net Cash Flow from Operations | -5.53M | ||
| Share Based Compensation | 1.33M | ||